Publication Details
Abstract
This article explores the pathogenetic role of autoimmune mechanisms in the development and progression of thyroid diseases, particularly focusing on autoimmune thyroiditis and Graves' disease. The study delves into the immunological processes responsible for the body’s production of autoantibodies targeting thyroid antigens such as thyroglobulin (Tg), thyroid peroxidase (TPO), and the TSH receptor. It is emphasized that the dysregulation of immune tolerance and the subsequent activation of autoreactive T and B lymphocytes play a central role in the initiation and perpetuation of thyroid autoimmunity. The article presents findings from both clinical observations and laboratory analyses that demonstrate the correlation between elevated levels of thyroid-specific autoantibodies and the severity of thyroid dysfunction. In Hashimoto's thyroiditis, for instance, a gradual destruction of thyroid follicles due to lymphocytic infiltration and cytokine-mediated damage leads to hypothyroidism. Conversely, in Graves’ disease, stimulating autoantibodies mimic TSH, leading to sustained overproduction of thyroid hormones and hyperthyroidism. The authors also consider the genetic and environmental factors contributing to the development of autoimmune thyroid diseases, including HLA gene polymorphisms, gender predisposition, infections, stress, and iodine intake. Furthermore, recent advances in the understanding of regulatory T-cell dysfunction and epigenetic influences are highlighted as pivotal contributors to the loss of immune tolerance in thyroid tissue. This study underscores the importance of identifying autoimmune markers for early diagnosis, prognosis, and personalized treatment approaches. It concludes that a better understanding of the pathogenetic significance of autoimmune processes could pave the way for novel therapeutic strategies, including immunomodulatory and targeted biological treatments.